LSD
LSD is a peptide. LSD can specifically recognize the lymphatics of C8161 melanoma, but it does not bind to the lymphatics of normal tissues or tumor blood vessels. When conjugated with a proapoptotic peptide, LSD can reduce the number of tumor lymphatics. LSD can be used in the research of targeted therapy and diagnosis of tumor lymphatics[1].
Product Specifications
CAS Number
[945245-76-1]
UNSPSC
12352209
Target
Biochemical Assay Reagents
Type
Peptides
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lsd.html
Purity
98.11
Solubility
10 mM in DMSO
Smiles
Molecular Formula
C39H72N14O13S2
Molecular Weight
1009.20
References & Citations
[1]Zhang L, et al. Lymphatic zip codes in premalignant lesions and tumors. Cancer Res. 2006 Jun 1;66 (11) :5696-706.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Phase 2
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items